Advisors Capital Management LLC Buys Shares of 1,851 Cardinal Health, Inc. $CAH

Advisors Capital Management LLC bought a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund bought 1,851 shares of the company’s stock, valued at approximately $255,000.

Several other institutional investors and hedge funds also recently bought and sold shares of CAH. Greykasell Wealth Strategies Inc. purchased a new position in Cardinal Health during the 1st quarter valued at about $26,000. Jones Financial Companies Lllp grew its stake in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares in the last quarter. Tompkins Financial Corp grew its stake in Cardinal Health by 106.7% during the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company’s stock valued at $34,000 after acquiring an additional 128 shares in the last quarter. GW&K Investment Management LLC grew its stake in Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after acquiring an additional 144 shares in the last quarter. Finally, NBC Securities Inc. purchased a new position in Cardinal Health during the 1st quarter valued at about $48,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Down 0.1%

Shares of Cardinal Health stock opened at $152.34 on Friday. The stock has a market capitalization of $36.38 billion, a P/E ratio of 23.62, a PEG ratio of 1.29 and a beta of 0.73. The stock has a 50 day moving average price of $154.50 and a two-hundred day moving average price of $147.79. Cardinal Health, Inc. has a 12-month low of $106.54 and a 12-month high of $168.44.

Cardinal Health (NYSE:CAH) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. The firm had revenue of $60.16 billion during the quarter, compared to analysts’ expectations of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company’s revenue was up .5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. Cardinal Health’s payout ratio is 31.63%.

Analyst Ratings Changes

Several research firms have weighed in on CAH. Morgan Stanley reaffirmed an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Robert W. Baird boosted their price target on Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research note on Wednesday, August 13th. Argus set a $189.00 price target on Cardinal Health in a research note on Friday, August 22nd. Wells Fargo & Company reissued an “overweight” rating and issued a $185.00 price target (up previously from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Finally, Jefferies Financial Group set a $150.00 price target on Cardinal Health in a research note on Tuesday, August 12th. Eleven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and a consensus target price of $165.93.

Insider Activity at Cardinal Health

In other news, insider Ola M. Snow sold 28,151 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the transaction, the insider directly owned 15,431 shares in the company, valued at $2,298,293.14. The trade was a 64.59% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jason M. Hollar sold 107,705 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.90, for a total value of $16,037,274.50. Following the transaction, the chief executive officer owned 235,901 shares of the company’s stock, valued at approximately $35,125,658.90. This trade represents a 31.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 271,676 shares of company stock valued at $40,489,525. 0.09% of the stock is owned by corporate insiders.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.